Feasibility of “Sit Less, Move More”: An intervention for reducing sedentary behavior Among African Americans with MS

• Published in: Multiple sclerosis journal - experimental, translational and clinical translational and clinical, 2020-04, Vol.6 (2), p.2055217320932341-2055217320932341
• Main Authors: Baird, Jessica F., Sasaki, Jeffer E., Sandroff, Brian M., Cutter, Gary R., Motl, Robert W.
• Format: Article
• Language: English
• Subjects: African Americans; Behavior modification; Feasibility studies; Health behavior; Multiple sclerosis; Original Research Paper; Sedentary behavior
• ISSN: 2055-2173; 2055-2173
• DOI: 10.1177/2055217320932341

Background Sedentary behavior is a major concern in multiple sclerosis, as it may accelerate disease progression and physical disability. This is especially concerning in African Americans, who present with greater neurological disability than Caucasians. Objective We conducted a feasibility trial on an intervention targeting sedentary behavior in African Americans with multiple sclerosis. Methods We examined the feasibility of the Sit Less, Move More program, a 12-week behavioral intervention that used text messaging along with theory-driven newsletters and behavioral coaching for managing sedentary behavior. We recruited ambulatory, inactive, African Americans with multiple sclerosis, and assessed feasibility on process, resource, management, and scientific outcomes. Results Of the 64 people initially contacted, 45 were assessed for eligibility, 31 were sent the informed consent document, and 30 returned a signed document and were included in the study. Study costs were US$7242.38. Personnel time to complete the study was 130 h. There was a small effect on both device-measured (d = −0.19) and self-reported (d = −0.39) sedentary behavior. Conclusions The Sit Less, Move More intervention is safe and feasible for African Americans with multiple sclerosis, and yielded a small reduction in sedentary behavior. The intervention was low cost and well received. Our results suggest the Sit Less, Move More program should progress towards a Phase II trial to determine its efficacy.